{"id":"W2121098984","doi":"10.1126/scitranslmed.aac9511","title":"Plasma <i>AR</i> and abiraterone-resistant prostate cancer","year":2015,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":441,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Prostate Cancer UK; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Abiraterone; Prostate cancer; Medicine; Cancer; Abiraterone acetate; Prostate; Oncology; Internal medicine; Urology; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004447569,0.0002099045,0.0003051749,0.0003318201,0.0002779379,0.0005435062,0.000304238,0.0003377879,0.00108101],"category_scores_gemma":[0.001313343,0.0001973404,0.0003036608,0.0003739614,0.0003237709,0.0001902634,0.0002561007,0.000682026,0.0001441617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004237389,"about_ca_system_score_gemma":0.0004720249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002777694,"about_ca_topic_score_gemma":0.002556779,"domain_scores_codex":[0.9995149,0.0001221055,0.00003344397,0.0001095958,0.0001585478,0.00006130151],"domain_scores_gemma":[0.9986109,0.0003595341,0.0006510039,0.00009533318,0.00009050555,0.0001926735],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001710079,0.00006435328,0.9790654,0.00002901462,0.0001217734,0.0004935801,0.00006461606,0.0003174368,0.01001186,0.00008451789,0.0001448873,0.00789241],"study_design_scores_gemma":[0.0000552559,0.0005539173,0.9913629,0.000008995639,0.0001065927,0.003026086,0.0001166524,0.001330916,0.002599957,0.0002016894,0.0006262714,0.00001069755],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99857,0.0006090557,0.0002818056,0.00005168639,0.000006091628,0.000004702785,0.00008512856,0.00001203253,0.0003796235],"genre_scores_gemma":[0.9995801,0.0001024884,0.0001021653,0.00002719303,0.00001068662,0.000001931669,0.00008531615,0.000001857771,0.0000882919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002777694,"threshold_uncertainty_score":0.005523026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06533960079360934,"score_gpt":0.36954620893229,"score_spread":0.3042066081386806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}